Abstract
The antiparasitic activity of ivermectin depends on the presence of an active drug concentration at the site of parasites location for an adapted length of time. Ivermectin interactions with another concurrently administered drug can occur. Concomitant administration of some drugs can increase the bioavailability of simultaneously administered ivermectin. This can, in some cases, become a useful pharmacological strategy to improve its antiparasitic efficacy and to delay the development of resistance in livestock or, in other cases, lead to adverse drug reactions and toxicities. On the other hand, other interactions can result in lower levels of this drug, determining that moderate resistant residual populations of the parasites may persist to contaminate pastures. The characterisation of ivermectin interactions can be used to predict and optimise the value of the parasiticide effects. This article reviews the pharmacological interactions of ivermectin in several domestic animal species.
Keywords: Ivermectin, pharmacokinetic interactions, pharmacodynamic interactions, veterinary
Current Drug Metabolism
Title: A Review of the Pharmacological Interactions of Ivermectin in Several Animal Species
Volume: 10 Issue: 4
Author(s): Aranzazu Gonzalez-Canga, Nelida Fernandez-Martinez, Ana Sahagun-Prieto, M. Jose Diez-Liebana, Matilde Sierra-Vega and Juan J. Garcia-Vieitez
Affiliation:
Keywords: Ivermectin, pharmacokinetic interactions, pharmacodynamic interactions, veterinary
Abstract: The antiparasitic activity of ivermectin depends on the presence of an active drug concentration at the site of parasites location for an adapted length of time. Ivermectin interactions with another concurrently administered drug can occur. Concomitant administration of some drugs can increase the bioavailability of simultaneously administered ivermectin. This can, in some cases, become a useful pharmacological strategy to improve its antiparasitic efficacy and to delay the development of resistance in livestock or, in other cases, lead to adverse drug reactions and toxicities. On the other hand, other interactions can result in lower levels of this drug, determining that moderate resistant residual populations of the parasites may persist to contaminate pastures. The characterisation of ivermectin interactions can be used to predict and optimise the value of the parasiticide effects. This article reviews the pharmacological interactions of ivermectin in several domestic animal species.
Export Options
About this article
Cite this article as:
Gonzalez-Canga Aranzazu, Fernandez-Martinez Nelida, Sahagun-Prieto Ana, Diez-Liebana Jose M., Sierra-Vega Matilde and Garcia-Vieitez J. Juan, A Review of the Pharmacological Interactions of Ivermectin in Several Animal Species, Current Drug Metabolism 2009; 10 (4) . https://dx.doi.org/10.2174/138920009788498969
DOI https://dx.doi.org/10.2174/138920009788498969 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Tissue Distribution and Metabolism of Micro- and Nanoparticles and Medical Implants
With the continuous advancement of modern science and engineering, numerous functional materials and active molecules have been developed and utilized in various industrial, medical, and food applications. Many of these can enter the body, either actively or passively, and have significant and intricate impacts on human health. For example, biomaterials ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Applications of Autoimmunity to Citrullinated Proteins in Rheumatoid Arthritis, from Improving Diagnostics to Future Therapies
Recent Patents on Inflammation & Allergy Drug Discovery Editorial [Hot topic: Updates on Therapeutic Approaches to Inflammatory Skin Diseases: From Molecular Targets to Drug Development. Part II (Guest Editors: L. Korkina & S. Pastore)]
Current Drug Metabolism NF-κB as a Target for Modulating Inflammatory Responses
Current Pharmaceutical Design Reactions of Carbenoids and Ketenes from α-Diazocarbonyls and Their Applications in Natural Products Synthesis
Current Organic Chemistry Novel Formulations for Oral Allergen Vaccination
Recent Patents on Inflammation & Allergy Drug Discovery Editorial (Thematic Issue: Biomarkers in the Management of Chronic Lung Disease)
Current Topics in Medicinal Chemistry Advances and Challenges in Drug Design of PPARδ Ligands
Current Drug Targets Lipid Mediators: Lipoxin and Aspirin-Triggered 15-Epi-Lipoxins
Inflammation & Allergy - Drug Targets (Discontinued) Erythropoietin: A Neuroprotective Agent in Cerebral Hypoxia, Neurodegeneration, and Epilepsy
Current Pharmaceutical Design Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Current Stem Cell Research & Therapy Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Current Drug Safety Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Current Pharmaceutical Design Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity
Current Molecular Medicine β-D-Mannuronic Acid (M2000) as a Landmark in Pharmacology
Current Drug Discovery Technologies The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age
Current Neuropharmacology Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Current Pharmaceutical Design They Must Hold Tight: Junction Proteins, Microbiota And Immunity In Intestinal Mucosa
Current Protein & Peptide Science Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach
Current Pharmaceutical Design Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1
Current Molecular Pharmacology